ACRV - Acrivon Therapeutics, Inc.

1.23
-0.100   -8.130%

Share volume: 685,090
Last Updated: 05-07-2025
Pharmaceutical Products/Pharmaceutical Preparations: -0.13%

PREVIOUS CLOSE
CHG
CHG%
$1.33
-0.10
-0.08%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Income statement Balance sheet Cash flow To see more then 2 years history Buy Premium
View ratios

Fiscal Date 03-31-2023 06-30-2023 09-30-2023 12-31-2023 03-31-2024 06-30-2024 09-30-2024 12-31-2024
Fiscal Quarter Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Report Date 05-14-2024 08-13-2024 11-09-2023 11-13-2024 05-14-2024 08-13-2024 11-13-2024 03-27-2025
Total revenue 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Cost of revenue 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Gross profit 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
    nan% nan% nan%   nan% nan% nan%  
Operating expenses 14.393 M 15.520 M 16.137 M 0.000 17.668 M 21.437 M 25.140 M 24.954 M
Selling general and admin 4.635 M 4.999 M 5.870 M 0.000 6.195 M 6.412 M 6.276 M 6.324 M
Research and development 9.758 M 10.521 M 10.267 M 0.000 11.473 M 15.025 M 18.864 M 18.630 M
Total expenses 14.393 M 15.520 M 16.137 M 0.000 17.668 M 21.437 M 25.140 M 24.954 M
    7.83% 3.98% -100.00%   21.33% 17.27% -0.74%  
Operating income -14.393 M -15.520 M -16.137 M 0.000 -17.668 M -21.437 M -25.140 M -24.954 M
Ebit -14.563 M -15.684 M -16.234 M 0.000 -17.932 M -21.492 M -25.139 M -25.194 M
Pretax income -12.756 M -13.914 M -14.466 M 0.000 -16.486 M -18.798 M -22.441 M -22.831 M
    9.08% 3.97% -100.00%   14.02% 19.38% 1.74%  
Income tax 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Net income basic 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
                   
Net income -12.756 M -13.914 M -14.466 M 0.000 -16.486 M -18.798 M -22.441 M -22.831 M
    -9.08% -3.97% 100.00%   -14.02% -19.38% -1.74%